COVID-19 Notice: We are fully operational and still taking new clients. Please do not hesitate to contact us!

Dangerous Drugs On Shelves: Why the FDA Doesn't Intervene

The Food and Drug Administration (FDA) is essentially the first and last name in pharmaceutical regulations in the United States. People from coast-to-coast have come to assume that the FDA tests drugs and medical substances for safety, giving its seal of approval if everything looks fine. Yet, if this was the case, why do so many pharmaceutical drugs cause serious illnesses and health complications each year before they get recalled?

The truth that you might not know is that the FDA does not test drugs initially. FDA approval only means a prescription substance is approved for its intended use, but it does not mean the FDA has tested it or verified its safety. This is understandably misleading to many people.

Who Tests Pharmaceutical Drugs If Not the FDA?

If you assumed that prescription medicines must be tested by someone before they go on shelves or advertised to medical groups, then you would be correct – but the party that does the testing might surprise you. For the most part, the only parties that test pharmaceutical drugs for defects and potential dangers are the pharmaceutical companies that manufacture them. The typical process includes the pharmaceutical company running its own tests until it is satisfied with the results, which are then sent to the FDA for approval. If the given information indicates the drug’s possible risks do not outweigh its potential benefits, then the FDA will likely approve it.

Inherent Problems with Self-Reviewing Pharmaceuticals

Asking a pharmaceutical company to research and test its own pharmaceuticals has some high potentiality for errors and biasness from an outside perspective. Knowing that no FDA approval could mean receiving no profits for its products, Big Pharma has all the more reason to do whatever it can to make their products look safe. It is not a stretch to imagine research data being hidden, exaggerated, or misconstrued in order to increase the likelihood the FDA will approve a drug for use and sale. The ongoing opioid crisis effectively began due to pharmaceutical companies advertising opiates as safe and non-addictive, with time proving the opposite.

Imagine if restaurants were allowed to conduct their own hygiene surveys and effectively choose their own health rating. Every single eatery would have an “A” and most of them would probably be in disarray in the kitchen. No one would approve such a self-serving system, yet it is allowed for pharmaceutical drugs that can cause significant health conditions if something goes wrong.

Florida Defective Pharmaceutical Attorney Wes Pittman

Do you need to file a product liability claim against a large pharmaceutical company or manufacturer? You can be sure of resistance from the defendant, likely resulting in litigation.

To give yourself the advantage, work with Attorney Wes Pittman of The Pittman Firm, P.A., located in Panama City but serving all of Florida. As a personal injury lawyer with more than 30 years of legal experience and a history of impressive case results, Wes Pittman is well-equipped to take on any challenge on your behalf. To learn how he and his firm can empower your claim after being hurt by a defective drug, call (850) 764-0383 for a no-cost consultation.


Contact The Pittman Firm, P.A. Today!

Hiring of a Florida injury lawyer is an important decision that should not be based solely upon advertisements. The firm will be happy to provide you with more information regarding Attorney Pittman’s qualifications and answer any questions you may have regarding your legal options.

Contact The Pittman Firm, P.A. now for the high-quality legal representation you need for your personal injury case.
  • Please enter your name.
  • This isn't a valid phone number.
    Please enter your phone number.
  • This isn't a valid email address.
    Please enter your email address.
  • Please make a selection.
  • Please enter the state.
  • Please enter a message.